# Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

> **NCT00642616** · PHASE3 · TERMINATED · sponsor: **Mannkind Corporation** · enrollment: 34 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Moderate Chronic Obstructive Pulmonary Disease
- Asthma

## Interventions

- **DRUG:** Technosphere® Insulin
- **DRUG:** Usual Care

## Key facts

- **NCT ID:** NCT00642616
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Terminated upon recommendation of the Data Safety Monitoring Board (DSMB)
- **Last updated:** 2017-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00642616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00642616, "Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00642616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*